ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,193Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 559

$399K Total Retail Price of All Prescriptions

Rank: 64 out of 559

497 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

35% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 5,572 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
HYDROCODONE-ACETAMINOPHEN 562 300 S3 1 7
LISINOPRIL 554 387 2 1
METFORMIN HCL 333 249 3 5
OMEPRAZOLE 323 254 4 4
HYDROCHLOROTHIAZIDE 298 235 5 8
IBUPROFEN 278 166 6 30
MELOXICAM 249 189 7 42
AMLODIPINE BESYLATE 216 177 8 6
OXYCODONE HCL-ACETAMINOPHEN 169 53 S2 9 70
ALENDRONATE SODIUM 162 119 10 13
LEVOTHYROXINE SODIUM 162 125 10 2
SIMVASTATIN 149 122 12 3
METOPROLOL SUCCINATE 148 107 13 16
GLYBURIDE 136 98 R 14 45
RANITIDINE HCL 124 87 15 26
DIOVAN 119 92 16 55
TAMSULOSIN HCL 119 104 16 25
AZITHROMYCIN 117 87 18 39
ZOLPIDEM TARTRATE 109 63 19 17
ATORVASTATIN CALCIUM 108 80 20 20
ATENOLOL 98 56 21 15
SERTRALINE HCL 95 44 22 19
CYCLOBENZAPRINE HCL 94 73 R 23 54
NAPROXEN 92 36 24 79
CARISOPRODOL 89 24 R 25 73
FUROSEMIDE 88 74 26 11
GABAPENTIN 78 49 27 9
LEVEMIR FLEXPEN 72 58 28 127
POTASSIUM CHLORIDE 72 58 28 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 42 30 96
LANTUS SOLOSTAR 63 37 31 136
NEXIUM 61 51 32 57
LANTUS 55 30 33 40
CREON 53 40 34 249
FLUTICASONE PROPIONATE 53 29 34 22
METOPROLOL TARTRATE 53 39 34 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.